Education
About Us
Working with TipRanks
Follow Us
IR-Med (IRME)
OTHER OTC:IRME
IRME Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.05 - $1.00
Previous CloseN/A
Volume729.00
Average Volume (3M)13.94K
Market Cap
$5.55M
Enterprise Value$8.59M
Total Cash (Recent Filing)$51.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding72,018,140
10 Day Avg. Volume6,575
30 Day Avg. Volume13,937
Financial Highlights & Ratios
PEG Ratio3.08
Price to Book (P/B)-17.20
Price to Sales (P/S)0.00
P/FCF Ratio-7.59
Enterprise Value/Market Cap1.55
Enterprise Value/Revenue126.34
Enterprise Value/Gross Profit-2.15K
Enterprise Value/Ebitda-0.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IR-Med News
PremiumCompany Announcements
IR-Med Appoints Yechiel Even as New Director
PremiumCompany Announcements
IR-Med Enters Note Purchase Agreement with Investors
PremiumCompany Announcements
IR-Med Delays Annual Report Filing
PremiumCompany Announcements
IR-Med Releases Updated Investor Presentation Online
PremiumCompany Announcements
IR-Med Appoints Ran Ziskind as CEO with Strategic IncentivesPremiumCompany Announcements
IR-Med Revises Executive Pay Agreements for CEO and CSO
PremiumCompany Announcements
IR-Med Expands Board and Increases Capital through Private PlacementPremiumCompany Announcements
IR-Med Announces Aharon Klein as Interim CEOIRME FAQ
What was IR-Med’s price range in the past 12 months?
IR-Med lowest stock price was $0.05 and its highest was $1.00 in the past 12 months.
What is IR-Med’s market cap?
IR-Med’s market cap is $5.55M.
When is IR-Med’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IR-Med’s earnings last quarter?
Currently, no data Available
Is IR-Med overvalued?
According to Wall Street analysts IR-Med’s price is currently Overvalued.
Does IR-Med pay dividends?
IR-Med does not currently pay dividends.
What is IR-Med’s EPS estimate?
IR-Med’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IR-Med have?
IR-Med has 72,018,140 shares outstanding.
What happened to IR-Med’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IR-Med?
Currently, no hedge funds are holding shares in IRME
Company Description
IR-Med
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.